Sanofi S.A. Overview
Pro stress-test →Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The company discovers, develops, manufactures, and markets an array of medicines and vaccines, with its portfolio including medicines for cancer, rare diseases, and multiple sclerosis; human vaccines for protection against various bacterial and viral diseases; and other products.
Strategic Profile
Pro stress-test →In 2025, sales increased by 9.9% at constant exchange rates, while business EPS improved significantly faster by 15.0%. The company leverages AI-driven supply chain management that enabled it to avoid $300 million in revenue risk, and combining machine learning with lab research has helped discover 10 completely new drug targets in just one year.
Competitive Landscape
Pro stress-test →Top competitors include Merck, AbbVie, and Amgen. Sanofi competes in highly competitive specialty pharma and vaccine markets with other diversified players like Johnson & Johnson, Roche, and Novartis, differentiating through its large portfolio breadth, emerging vaccine franchise, and rare disease expertise.
Industry Context
Sanofi S.A. operates in Biopharmaceuticals - Pharmaceuticals & Vaccines.
Key facts
Founded: 1973 · Headquarters: Paris, France · Revenue: EUR 43.6B (2025)